SciBase Sees Increased Investment from Major Shareholders

Sep 11, 2025
SciBase's main shareholders, Ribbskottet AB and Life Science Investment Fund, have each acquired 7.5 million shares in a recent block trade, strengthening their positions in the AI-based dermatology company.

SciBase, a leader in AI-based dermatology devices, has seen a significant increase in investment from its main shareholders. Announced in a press release, Ribbskottet AB and Life Science Investment Fund have each purchased approximately 7.5 million shares in a block trade. This transaction was conducted off the stock exchange from larger long-term owners.

Anders Bladh, CEO of Ribbskottet AB, expressed confidence in SciBase's growth and potential, citing the company's recent collaborations, including one with Castle Biosciences Inc. Jan Poulsen, CEO of Life Science Investment Fund, also highlighted the compelling investment opportunity presented by SciBase's current valuation.

SciBase specializes in early detection and prevention in dermatology, utilizing its Nevisense platform that combines AI and advanced EIS technology to enhance diagnostic accuracy. The company has been listed on the Nasdaq First North Growth Market since 2015.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.